New research published in the British Medical Journal warns that stopping GLP-1 drugs like Ozempic can lead to rapid weight gain and increased risks of diabetes and heart disease. Meanwhile, CNBC reports that Wall Street analysts at Jeffrey predict airlines will save significantly on fuel costs as the population loses weight. The FDA has also reportedly removed warnings regarding suicidal tendencies from these medications.














